435 related articles for article (PubMed ID: 33717144)
21. Novel signal transducer and activator of transcription 3 (STAT3) mutations, reduced T(H)17 cell numbers, and variably defective STAT3 phosphorylation in hyper-IgE syndrome.
Renner ED; Rylaarsdam S; Anover-Sombke S; Rack AL; Reichenbach J; Carey JC; Zhu Q; Jansson AF; Barboza J; Schimke LF; Leppert MF; Getz MM; Seger RA; Hill HR; Belohradsky BH; Torgerson TR; Ochs HD
J Allergy Clin Immunol; 2008 Jul; 122(1):181-7. PubMed ID: 18602572
[TBL] [Abstract][Full Text] [Related]
22. Elevated serum immunoglobulin E (IgE): when to suspect hyper-IgE syndrome-A 10-year pediatric tertiary care center experience.
Joshi AY; Iyer VN; Boyce TG; Hagan JB; Park MA; Abraham RS
Allergy Asthma Proc; 2009; 30(1):23-7. PubMed ID: 19331717
[TBL] [Abstract][Full Text] [Related]
23. TH17 Cells in STAT3 Related Hyper-IgE Syndrome.
Sharma S; Saikia B; Goel S; Rawat A; Minz RW; Suri D; Chhabra S; Singh S
Indian J Pediatr; 2016 Oct; 83(10):1104-8. PubMed ID: 27226025
[TBL] [Abstract][Full Text] [Related]
24. Dominant-negative signal transducer and activator of transcription (STAT)3 variants in adult patients: A single center experience.
Shamriz O; Rubin L; Simon AJ; Lev A; Barel O; Somech R; Korem M; Matza Porges S; Freund T; Hagin D; Garty BZ; Nahum A; Molho Pessach V; Tal Y
Front Immunol; 2022; 13():1044933. PubMed ID: 36605204
[TBL] [Abstract][Full Text] [Related]
25. Clinical manifestations, etiology, and pathogenesis of the hyper-IgE syndromes.
Freeman AF; Holland SM
Pediatr Res; 2009 May; 65(5 Pt 2):32R-37R. PubMed ID: 19190525
[TBL] [Abstract][Full Text] [Related]
26. Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: molecular, cellular, and clinical features from a French national survey.
Chandesris MO; Melki I; Natividad A; Puel A; Fieschi C; Yun L; Thumerelle C; Oksenhendler E; Boutboul D; Thomas C; Hoarau C; Lebranchu Y; Stephan JL; Cazorla C; Aladjidi N; Micheau M; Tron F; Baruchel A; Barlogis V; Palenzuela G; Mathey C; Dominique S; Body G; Munzer M; Fouyssac F; Jaussaud R; Bader-Meunier B; Mahlaoui N; Blanche S; Debré M; Le Bourgeois M; Gandemer V; Lambert N; Grandin V; Ndaga S; Jacques C; Harre C; Forveille M; Alyanakian MA; Durandy A; Bodemer C; Suarez F; Hermine O; Lortholary O; Casanova JL; Fischer A; Picard C
Medicine (Baltimore); 2012 Jul; 91(4):e1-e19. PubMed ID: 22751495
[TBL] [Abstract][Full Text] [Related]
27. Clinical, immunological and genetic features in Taiwanese patients with the phenotype of hyper-immunoglobulin E recurrent infection syndromes (HIES).
Lee WI; Huang JL; Lin SJ; Yeh KW; Chen LC; Ou LS; Yao TC; Hsieh MY; Huang YC; Yu HR; Kuo HC; Yang KD; Jaing TH
Immunobiology; 2011 Aug; 216(8):909-17. PubMed ID: 21324546
[TBL] [Abstract][Full Text] [Related]
28. Pulmonary Infections and Surgical Complications in a Young Girl with Signal Transducer and Activator of Transcription 3 Loss-of-Function Mutation Hyperimmunoglobulin E Syndrome: A Case Report.
Toribio-Dionicio C; Cubas-Guzmán D; Guerra-Canchari P; García-Sánchez V; Córdova-Calderón W
Pediatr Allergy Immunol Pulmonol; 2021 Mar; 34(1):33-37. PubMed ID: 33734873
[No Abstract] [Full Text] [Related]
29. Clinical aspects and genetic analysis of Taiwanese patients with the phenotype of hyper-immunoglobulin E recurrent infection syndromes (HIES).
Lee WI; Huang JL; Lin SJ; Yeh KW; Chen LC; Hsieh MY; Huang YC; Kuo HC; Yang KD; Yu HR; Jaing TH; Yang CH
J Clin Immunol; 2011 Apr; 31(2):272-80. PubMed ID: 21120687
[TBL] [Abstract][Full Text] [Related]
30. Investigation of Skin Barrier Functions and Allergic Sensitization in Patients with Hyper-IgE Syndrome.
Mócsai G; Gáspár K; Dajnoki Z; Tóth B; Gyimesi E; Bíró T; Maródi L; Szegedi A
J Clin Immunol; 2015 Oct; 35(7):681-8. PubMed ID: 26453584
[TBL] [Abstract][Full Text] [Related]
31. Clinical manifestations of hyper IgE syndromes.
Freeman AF; Holland SM
Dis Markers; 2010; 29(3-4):123-30. PubMed ID: 21178271
[TBL] [Abstract][Full Text] [Related]
32. Human hyper-IgE syndrome: singular or plural?
Zhang Q; Boisson B; Béziat V; Puel A; Casanova JL
Mamm Genome; 2018 Aug; 29(7-8):603-617. PubMed ID: 30094507
[TBL] [Abstract][Full Text] [Related]
33. Novel STAT3 mutation causing hyper-IgE syndrome: studies of the clinical course and immunopathology.
Sundin M; Tesi B; Sund Böhme M; Bryceson YT; Pütsep K; Chiang SC; Thunberg S; Winiarski J; Wikström AC
J Clin Immunol; 2014 May; 34(4):469-77. PubMed ID: 24627079
[TBL] [Abstract][Full Text] [Related]
34. Hyper-IgE syndrome with STAT3 mutation: a case report in Mainland China.
Xie L; Hu X; Li Y; Zhang W; Chen L
Clin Dev Immunol; 2010; 2010():289873. PubMed ID: 20490271
[TBL] [Abstract][Full Text] [Related]
35. SH2-domain mutations in STAT3 in hyper-IgE syndrome patients result in impairment of IL-10 function.
Giacomelli M; Tamassia N; Moratto D; Bertolini P; Ricci G; Bertulli C; Plebani A; Cassatella M; Bazzoni F; Badolato R
Eur J Immunol; 2011 Oct; 41(10):3075-84. PubMed ID: 21792878
[TBL] [Abstract][Full Text] [Related]
36. The Potential and Limits of Hematopoietic Stem Cell Transplantation for the Treatment of Autosomal Dominant Hyper-IgE Syndrome.
Yanagimachi M; Ohya T; Yokosuka T; Kajiwara R; Tanaka F; Goto H; Takashima T; Morio T; Yokota S
J Clin Immunol; 2016 Jul; 36(5):511-6. PubMed ID: 27091139
[TBL] [Abstract][Full Text] [Related]
37. Pathogenesis of hyper IgE syndrome.
Heimall J; Freeman A; Holland SM
Clin Rev Allergy Immunol; 2010 Feb; 38(1):32-8. PubMed ID: 19452285
[TBL] [Abstract][Full Text] [Related]
38. Hyperimmunoglobulin E syndromes in pediatrics.
Zhang Q; Su HC
Curr Opin Pediatr; 2011 Dec; 23(6):653-8. PubMed ID: 21970826
[TBL] [Abstract][Full Text] [Related]
39. A systematic review regarding the prevalence of malignancy in patients with the hyper-IgE syndrome.
Mohammadi T; Azizi G; Rafiemanesh H; Farahani P; Nirouei M; Tavakol M
Clin Exp Med; 2023 Dec; 23(8):4835-4859. PubMed ID: 37924455
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of the Role of
Moffitt K; Cheung E; Manis J; Malley R
Infect Immun; 2018 May; 86(5):. PubMed ID: 29463618
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
